Metabolic and Kidney Disorders Correlate with High Atazanavir Concentrations in HIV-Infected Patients: Is It Time to Revise Atazanavir Dosages?

Cristina Gervasoni, Dario Cattaneo, Davide Minisci et al.|PLoS ONE|2015

Cited by 28